| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 42,813 | 41,131 | 38,623 | 37,363 | | Cost of Revenue | 22,199 | 22,332 | 20,472 | 19,708 | | | Gross Profit | 20,614 | 18,799 | 18,151 | 17,655 | | | Operating Expenses | | Research Development | 2,187 | 1,831 | 1,825 | 1,982 | | Selling General and Administrative | 14,812 | 15,128 | 14,936 | 13,780 | | Non Recurring | 125 | 83 | 42 | 104,410 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,490 | 1,757 | 1,348 | (102,517) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (201) | (55) | 216 | 66 | | Earnings Before Interest And Taxes | 3,289 | 1,702 | 1,564 | (102,451) | | Interest Expense | 138 | 130 | 123 | 250 | | Income Before Tax | 3,151 | 1,572 | 1,441 | (102,701) | | Income Tax Expense | 838 | 551 | 409 | (186) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,313 | 1,021 | 1,032 | (102,515) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,313 | 1,021 | 1,032 | (102,515) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,313 | $1,021 | $1,032 | ($102,515) |
|
0.04% Nasdaq 
0.23%
Income Statement
